Radiation DosageRadiation InjuriesRadiation, IonizingDose-Response Relationship, RadiationAntineoplastic AgentsRadiation ToleranceRadiationRadiation ProtectionRadiotherapyRadiotherapy DosageRadiation MonitoringRadiation OncologyCombined Modality TherapyNeoplasmsCell Line, TumorRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedDrug Screening Assays, AntitumorRadiation PneumonitisDose FractionationRadiotherapy Planning, Computer-AssistedRadiometryRadiation Injuries, ExperimentalDoxorubicinRadiotherapy, AdjuvantNeoplasms, Radiation-InducedRadiation-Sensitizing AgentsGamma RaysCosmic RadiationApoptosisBrachytherapyCisplatinCell SurvivalTreatment OutcomeDrug Resistance, NeoplasmAntineoplastic Agents, PhytogenicBackground RadiationRadiosurgeryBrain NeoplasmsDNA DamageRadiation-Protective AgentsUltraviolet RaysAntibiotics, AntineoplasticBreast NeoplasmsTime FactorsRadiotherapy, Computer-AssistedTumor Cells, CulturedDrug Delivery SystemsMice, NudeXenograft Model Antitumor AssaysRadiation EffectsParticle AcceleratorsAntineoplastic Combined Chemotherapy ProtocolsCranial IrradiationHead and Neck NeoplasmsRadiodermatitisNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedDrug CarriersCobalt RadioisotopesEtoposidePaclitaxelRadiotherapy, High-EnergyCell ProliferationFluorouracilRadiobiologyOrgans at RiskCarcinoma, Squamous CellNeoplasm StagingX-RaysAdenocarcinomaEllipticinesAcute Radiation SyndromeCamptothecinRetrospective StudiesProstatic NeoplasmsDose-Response Relationship, DrugTumor BurdenLung NeoplasmsTomography, X-Ray ComputedChemoradiotherapyCell CycleSurvival AnalysisDNA RepairRadioactive Hazard ReleaseInhibitory Concentration 50Disease-Free SurvivalDrug Resistance, MultipleMolecular StructureP-GlycoproteinSurvival RateFollow-Up StudiesLinear Energy TransferRelative Biological EffectivenessGlioblastomaRadiation Hybrid MappingDrug SynergismAntineoplastic Agents, AlkylatingAntimetabolites, AntineoplasticTumor Suppressor Protein p53